Distinction between glioma progression and post-radiation change by combined physiologic MR imaging

Neuroradiology

Volumn 52, Issue 4, 2010, Pages 297-306

  Matsusue, Eiji ^a,b   Fink, James R ^a   Rockhill, Jason K ^a   Ogawa, Toshihide ^b   Maravilla, Kenneth R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Glioma; MR diffusion; MR perfusion; MR spectroscopy; Radiation; Recurrence

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; BLOOD VOLUME; CEREBRAL BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; BRAIN; BRAIN CIRCULATION; BRAIN TUMOR; FOLLOW UP; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PILOT STUDY; RADIATION EXPOSURE; SCINTIGRAPHY; TUMOR RECURRENCE;

ADULT; ASPARTIC ACID; BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CHOLINE; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERFUSION IMAGING; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 77953049211     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-009-0613-9     Document Type: Article

References (23)

1. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am JNeuroradiol 26:1967-1972
2. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy induced necrosis of the brain after treatment. Radiology 217:377-384
3. Zeng QS, Li CF, Liu H, Zhen JH, Feng DC (2007) Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys 78:151-158
4. Lam WW, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of gliomas? Clin Radiol 57:219-225
5. Hein PA, Eskey CJ, Dunn JF, Hug EB (2004) Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation therapy. AJNR Am J Neuroradiol 25:201-209
6. Asao C, Korogi Y, Kitajima M et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455-1460
7. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, TakahashiM (2000) Post therapeutic intra axial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901-909
8. Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D (2000) Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21:881-890
9. Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M (2001) Perfusion sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 22:1306-1315
10. Liu G, Sobering G, Duyn J, Moonen CT (1993) A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO). Magn Reson Med 30:764-768
11. Manka C, Träber F, Gieseke J, Schild HH, Kuhl CK (2005) Threedimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0T: feasibility and contrast agent dose. Radiology 234:869-877
12. van Gelderen P, Grandin C, Petrella JR, Moonen CT (2000) Rapid three-dimensional MR imaging method for tracking a bolus of contrast agent through the brain. Radiology 216:603-608
13. Plotkin M, Eisenacher J, Bruhn H, Wurm R, Michel R, Stockhammer F, Feussner A, Dudeck O,Wust P, Felix R, Amthauer H (2004) 123IIMT SPECT and 1HMR-spectroscopy at 3.0T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 70:49-58
14. Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, Nakao N, Matsumoto T, Arita N (2004) Usefulness of Cho/Cr ratio in protonMR spectroscopy for differentiating residual/ recurrent glioma from non-neoplastic lesions. Nippon Igaku Hoshasen Gakkai Zasshi 64:121-126
15. Zeng QS, Li CF, Kai Z, Liu H, Kang XS, Zhen JH (2007) Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 84:63-69
16. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T (2002) Correlations between magnetic resonance spectoroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912-920
17. Weybright P, Sundgren PC, Maly P, Hassan DG, Nan B, Rohrer S, Junck L (2005) Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 185:1471-1476
18. Lichy MP, Henze M, Plathow C, Bachert P, Kauczor HU, Schlemmer HP (2004) Metabolic imaging to follow stereotactic radiation of gliomas the role of 1H MR spectroscopy in comparison to FDG PET and IMT-SPECT. Rofo 176:1114-1121
19. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 22:1316-1324
20. Di Chiro G, Oldfield E, Wright DC (1988) Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 150:189-197 (Pubitemid 18027033)
21. Langleben DD, Segall GM(2000) PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41:1861-1867
22. Wang SX, Boethius J, Ericson K (2006) FDG-PET on irradiated brain tumor: ten years' summary. Acta Radiol 47:85-90
23. Kim JH, Chang KH, Na DG, Song IC, Kwon BJ, Han MH, Kim K (2006) 3T H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiology 27:1412-1418